![Cancers | Free Full-Text | Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies in Los Angeles County and Their Association with CA 19-9 Levels Cancers | Free Full-Text | Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies in Los Angeles County and Their Association with CA 19-9 Levels](https://pub.mdpi-res.com/cancers/cancers-15-01723/article_deploy/html/images/cancers-15-01723-g001.png?1678530127)
Cancers | Free Full-Text | Clinical Features and Outcomes of Patients with Pancreaticobiliary Malignancies in Los Angeles County and Their Association with CA 19-9 Levels
![PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9bc6b05499723112efa11b692439ea1e9164a0fa/4-Table6-1.png)
PDF] Correlation between Tumour Marker CA 15-3 Level and TNM Staging in Breast Cancer. - | Semantic Scholar
![A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003269718304263-fx1.jpg)
A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect
![Cureus | A Rare Case of Non-immune Hemolytic Anemia in a Stage IV Breast Cancer Patient Treated With Capecitabine | Article Cureus | A Rare Case of Non-immune Hemolytic Anemia in a Stage IV Breast Cancer Patient Treated With Capecitabine | Article](https://assets.cureus.com/uploads/figure/file/370579/lightbox_6106f3b0c8c911ecbc25c95111518468-image.png)
Cureus | A Rare Case of Non-immune Hemolytic Anemia in a Stage IV Breast Cancer Patient Treated With Capecitabine | Article
![Comparison of the results of five tumor markers measured by the UniCel... | Download Scientific Diagram Comparison of the results of five tumor markers measured by the UniCel... | Download Scientific Diagram](https://www.researchgate.net/publication/223958841/figure/fig3/AS:667176570724367@1536078698603/Comparison-of-the-results-of-five-tumor-markers-measured-by-the-UniCel-TM-DxI-800-with.png)
Comparison of the results of five tumor markers measured by the UniCel... | Download Scientific Diagram
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig3_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![Linearity FD Tumor Markers, Calibration Verification Material, Linearity Test | AUDIT MicroControls, Inc. Linearity FD Tumor Markers, Calibration Verification Material, Linearity Test | AUDIT MicroControls, Inc.](https://www.auditmicro.com/media/catalog/product/cache/1/image/9df78eab33525d08d6e5fb8d27136e95/7/1/719.jpg)
Linearity FD Tumor Markers, Calibration Verification Material, Linearity Test | AUDIT MicroControls, Inc.
![Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram](https://www.researchgate.net/publication/24213426/figure/fig1/AS:460229222637571@1486738605171/Survival-curves-for-patients-with-CA-15-3-30-kU-l-and-no-metastasis-at-diagnosis-M2-as.png)
Survival curves for patients with CA 15-3 >30 kU/l and no metastasis at... | Download Scientific Diagram
![A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression | SpringerLink A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-016-4000-z/MediaObjects/10549_2016_4000_Fig3_HTML.gif)
A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression | SpringerLink
![Serum miR-155, miR-21, and CA 15.3 for diagnosis and monitoring therapy of breast cancer in females El Khateeb KO, Abonar AA, Ibrahim MM, Shalamesh MI - Al-Azhar Assiut Med J Serum miR-155, miR-21, and CA 15.3 for diagnosis and monitoring therapy of breast cancer in females El Khateeb KO, Abonar AA, Ibrahim MM, Shalamesh MI - Al-Azhar Assiut Med J](https://www.azmj.eg.net/articles/2021/19/4/images/Al-AzharAssiutMedJ_2021_19_4_496_332176_t4.jpg)
Serum miR-155, miR-21, and CA 15.3 for diagnosis and monitoring therapy of breast cancer in females El Khateeb KO, Abonar AA, Ibrahim MM, Shalamesh MI - Al-Azhar Assiut Med J
![Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-6-81/MediaObjects/12885_2006_Article_433_Fig1_HTML.jpg)
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment | BMC Cancer | Full Text
![Monitoring Patient B with advanced breast cancer by measuring serial... | Download Scientific Diagram Monitoring Patient B with advanced breast cancer by measuring serial... | Download Scientific Diagram](https://www.researchgate.net/publication/281540792/figure/fig2/AS:1088600691220493@1636554038447/Monitoring-Patient-B-with-advanced-breast-cancer-by-measuring-serial-concentrations-of-CA.jpg)
Monitoring Patient B with advanced breast cancer by measuring serial... | Download Scientific Diagram
![Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0009898115003265-t2.jpg)
Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer—A retrospective analysis of kinetics on 743 breast cancer patients - ScienceDirect
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure1.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression | SpringerLink A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-016-4000-z/MediaObjects/10549_2016_4000_Fig4_HTML.gif)